Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease
Methods for diagnosis, early diagnosis, differential diagnosis, assessment of the severity and therapy-accompanying monitoring and prognosis of chronically inflammatory intestinal diseases (Crohn's disease, Colitis ulcerosa ), in which the presence and/or the amount of one or more antibodies which bind to ribosomal proteins, in particular P0 and L5, are determined in the serum, plasma, tissue samples and/or stool of a patient who is suffering from a chronically inflammatory intestinal disease or in whom such a disease is suspected. The blocking or removal of such antibodies and/or the influencing of antigen-presenting cells or specifically reactive T-cells which react to ribosomal proteins, such as P0 and L5, by suitable agents can be therapeutically utilized.
1. A method for diagnosis of chronic inflammatory intestinal diseases, wherein the method comprises contacting a biological sample from a patient in whom chronic inflammatory intestinal disease is suspected with a molecule that detects an autoantibody directed to a ribosomal protein selected from P0 and L5, wherein the presence of said autoantibody indicates chronic inflammatory intestinal disease.
2. The method according to claim 1 , wherein the chronic inflammatory intestinal disease is selected from Crohn's disease and Colitis ulcerosa or their mixed form designated as Colitis indeterminate.
3. The method according to claim 2 , wherein said autoantibody is determined with the aid of an immunoassay in which the respective ribosomal protein in complete form or in the form of an adduct, or a phosphorylation product, is used as an antigen for binding and/or detecting the antibodies to be determined.
4. The method according to claim 1 , wherein said autoantibody is determined with the aid of an immunoassay in which the respective ribosomal protein in complete form or in the form of an adduct, or a phosphorylation product is used as an antigen for binding and/or detecting autoantibodies.
5. The method according to claim 4 , wherein the ribosomal protein is a human or animal protein which is enriched or isolated from natural sources or is recombinantly produced by a genetic engineering method.